1. Home
  2. AUID vs LIXT Comparison

AUID vs LIXT Comparison

Compare AUID & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.36

Market Cap

23.2M

Sector

Technology

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.05

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
LIXT
Founded
2009
2005
Country
United States
United States
Employees
N/A
4
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
25.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AUID
LIXT
Price
$1.36
$3.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
257.5K
34.3K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
N/A
Revenue
$886,485.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
365.86
N/A
52 Week Low
$0.84
$0.64
52 Week High
$9.44
$6.09

Technical Indicators

Market Signals
Indicator
AUID
LIXT
Relative Strength Index (RSI) 41.27 52.10
Support Level $1.19 $2.97
Resistance Level $1.38 $3.30
Average True Range (ATR) 0.11 0.27
MACD -0.02 0.02
Stochastic Oscillator 5.59 67.47

Price Performance

Historical Comparison
AUID
LIXT

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: